These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22593187)

  • 1. Integrin α5β1 plays a critical role in resistance to temozolomide by interfering with the p53 pathway in high-grade glioma.
    Janouskova H; Maglott A; Leger DY; Bossert C; Noulet F; Guerin E; Guenot D; Pinel S; Chastagner P; Plenat F; Entz-Werle N; Lehmann-Che J; Godet J; Martin S; Teisinger J; Dontenwill M
    Cancer Res; 2012 Jul; 72(14):3463-70. PubMed ID: 22593187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of p53 pathway by Nutlin-3a inhibits the expression of the therapeutic target α5 integrin in colon cancer cells.
    Janouskova H; Ray AM; Noulet F; Lelong-Rebel I; Choulier L; Schaffner F; Lehmann M; Martin S; Teisinger J; Dontenwill M
    Cancer Lett; 2013 Aug; 336(2):307-18. PubMed ID: 23523610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha5beta1 integrin antagonists reduce chemotherapy-induced premature senescence and facilitate apoptosis in human glioblastoma cells.
    Martinkova E; Maglott A; Leger DY; Bonnet D; Stiborova M; Takeda K; Martin S; Dontenwill M
    Int J Cancer; 2010 Sep; 127(5):1240-8. PubMed ID: 20099278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin α5β1 and p53 convergent pathways in the control of anti-apoptotic proteins PEA-15 and survivin in high-grade glioma.
    Renner G; Janouskova H; Noulet F; Koenig V; Guerin E; Bär S; Nuesch J; Rechenmacher F; Neubauer S; Kessler H; Blandin AF; Choulier L; Etienne-Selloum N; Lehmann M; Lelong-Rebel I; Martin S; Dontenwill M
    Cell Death Differ; 2016 Apr; 23(4):640-53. PubMed ID: 26470725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A stapled peptide antagonist of MDM2 carried by polymeric micelles sensitizes glioblastoma to temozolomide treatment through p53 activation.
    Chen X; Tai L; Gao J; Qian J; Zhang M; Li B; Xie C; Lu L; Lu W; Lu W
    J Control Release; 2015 Nov; 218():29-35. PubMed ID: 26428461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FERMT3 contributes to glioblastoma cell proliferation and chemoresistance to temozolomide through integrin mediated Wnt signaling.
    Lu C; Cui C; Liu B; Zou S; Song H; Tian H; Zhao J; Li Y
    Neurosci Lett; 2017 Sep; 657():77-83. PubMed ID: 28778805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEK-ERK signaling dictates DNA-repair gene MGMT expression and temozolomide resistance of stem-like glioblastoma cells via the MDM2-p53 axis.
    Sato A; Sunayama J; Matsuda K; Seino S; Suzuki K; Watanabe E; Tachibana K; Tomiyama A; Kayama T; Kitanaka C
    Stem Cells; 2011 Dec; 29(12):1942-51. PubMed ID: 21957016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward an effective strategy in glioblastoma treatment. Part I: resistance mechanisms and strategies to overcome resistance of glioblastoma to temozolomide.
    Messaoudi K; Clavreul A; Lagarce F
    Drug Discov Today; 2015 Jul; 20(7):899-905. PubMed ID: 25744176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gain of function of mutant TP53 in glioblastoma: prognosis and response to temozolomide.
    Wang X; Chen JX; Liu JP; You C; Liu YH; Mao Q
    Ann Surg Oncol; 2014 Apr; 21(4):1337-44. PubMed ID: 24248532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The sodium pump could constitute a new target to combat glioblastomas].
    Lefranc F; Mijatovic T; Kiss R
    Bull Cancer; 2008 Mar; 95(3):271-81. PubMed ID: 18390407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas.
    Chamberlain MC
    Expert Rev Neurother; 2010 Oct; 10(10):1537-44. PubMed ID: 20925470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted therapy based on p53 reactivation reduces both glioblastoma cell growth and resistance to temozolomide.
    Forte IM; Indovina P; Iannuzzi CA; Cirillo D; Di Marzo D; Barone D; Capone F; Pentimalli F; Giordano A
    Int J Oncol; 2019 Jun; 54(6):2189-2199. PubMed ID: 31081046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the TGFβ pathway in the regulation of α5 β1 integrins by caveolin-1 in human glioblastoma.
    Cosset EC; Godet J; Entz-Werlé N; Guérin E; Guenot D; Froelich S; Bonnet D; Pinel S; Plenat F; Chastagner P; Dontenwill M; Martin S
    Int J Cancer; 2012 Aug; 131(3):601-11. PubMed ID: 21901744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temozolomide and treatment of malignant glioma.
    Friedman HS; Kerby T; Calvert H
    Clin Cancer Res; 2000 Jul; 6(7):2585-97. PubMed ID: 10914698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression/activation of α5β1 integrin is linked to the β-catenin signaling pathway to drive migration in glioma cells.
    Renner G; Noulet F; Mercier MC; Choulier L; Etienne-Selloum N; Gies JP; Lehmann M; Lelong-Rebel I; Martin S; Dontenwill M
    Oncotarget; 2016 Sep; 7(38):62194-62207. PubMed ID: 27613837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of temozolomide resistance in glioblastoma multiforme.
    Johannessen TC; Bjerkvig R
    Expert Rev Anticancer Ther; 2012 May; 12(5):635-42. PubMed ID: 22594898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Green tea epigallocatechin gallate enhances therapeutic efficacy of temozolomide in orthotopic mouse glioblastoma models.
    Chen TC; Wang W; Golden EB; Thomas S; Sivakumar W; Hofman FM; Louie SG; Schönthal AH
    Cancer Lett; 2011 Mar; 302(2):100-8. PubMed ID: 21257259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic history of low-grade gliomas before and after temozolomide treatment.
    Ricard D; Kaloshi G; Amiel-Benouaich A; Lejeune J; Marie Y; Mandonnet E; Kujas M; Mokhtari K; Taillibert S; Laigle-Donadey F; Carpentier AF; Omuro A; Capelle L; Duffau H; Cornu P; Guillevin R; Sanson M; Hoang-Xuan K; Delattre JY
    Ann Neurol; 2007 May; 61(5):484-90. PubMed ID: 17469128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Aurora-B function increases formation of multinucleated cells in p53 gene deficient cells and enhances anti-tumor effect of temozolomide in human glioma cells.
    Tsuno T; Natsume A; Katsumata S; Mizuno M; Fujita M; Osawa H; Nakahara N; Wakabayashi T; Satoh Y; Inagaki M; Yoshida J
    J Neurooncol; 2007 Jul; 83(3):249-58. PubMed ID: 17570035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous IGFBP-2 promotes proliferation, invasion, and chemoresistance to temozolomide in glioma cells via the integrin β1-ERK pathway.
    Han S; Li Z; Master LM; Master ZW; Wu A
    Br J Cancer; 2014 Sep; 111(7):1400-9. PubMed ID: 25093489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.